Advertisement
UK markets close in 7 hours 25 minutes
  • FTSE 100

    8,077.51
    +37.13 (+0.46%)
     
  • FTSE 250

    19,621.36
    -98.01 (-0.50%)
     
  • AIM

    753.99
    -0.70 (-0.09%)
     
  • GBP/EUR

    1.1666
    +0.0021 (+0.18%)
     
  • GBP/USD

    1.2513
    +0.0050 (+0.40%)
     
  • Bitcoin GBP

    51,185.41
    -2,166.43 (-4.06%)
     
  • CMC Crypto 200

    1,331.30
    -51.28 (-3.58%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    83.07
    +0.26 (+0.31%)
     
  • GOLD FUTURES

    2,337.50
    -0.90 (-0.04%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,259.87
    +58.60 (+0.34%)
     
  • DAX

    18,012.18
    -76.52 (-0.42%)
     
  • CAC 40

    8,072.41
    -19.45 (-0.24%)
     

Is Sbanken ASA (OB:SBANK) Potentially Undervalued?

Sbanken ASA (OB:SBANK), operating in the financial services industry based in Norway, saw a double-digit share price rise of over 10% in the past couple of months on the OB. With many analysts covering the stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price. However, what if the stock is still a bargain? Let’s take a look at Sbanken’s outlook and value based on the most recent financial data to see if the opportunity still exists.

See our latest analysis for Sbanken

What's the opportunity in Sbanken?

Great news for investors – Sbanken is still trading at a fairly cheap price. According to my valuation, the intrinsic value for the stock is NOK69.90, which is above what the market is valuing the company at the moment. This indicates a potential opportunity to buy low. Sbanken’s share price also seems relatively stable compared to the rest of the market, as indicated by its low beta. If you believe the share price should eventually reach its true value, a low beta could suggest it is unlikely to rapidly do so anytime soon, and once it’s there, it may be hard to fall back down into an attractive buying range.

Can we expect growth from Sbanken?

OB:SBANK Past and Future Earnings March 27th 2020
OB:SBANK Past and Future Earnings March 27th 2020

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. Sbanken’s earnings over the next few years are expected to increase by 33%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value.

What this means for you:

Are you a shareholder? Since SBANK is currently undervalued, it may be a great time to accumulate more of your holdings in the stock. With a positive outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as capital structure to consider, which could explain the current undervaluation.

ADVERTISEMENT

Are you a potential investor? If you’ve been keeping an eye on SBANK for a while, now might be the time to make a leap. Its prosperous future outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy SBANK. But before you make any investment decisions, consider other factors such as the track record of its management team, in order to make a well-informed investment decision.

Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on Sbanken. You can find everything you need to know about Sbanken in the latest infographic research report. If you are no longer interested in Sbanken, you can use our free platform to see my list of over 50 other stocks with a high growth potential.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.